Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by barcodewhizon Sep 14, 2005 2:20pm
202 Views
Post# 9553206

RE: Big Deal

RE: Big Deal From the scuttlebut that I have heard, the board "retreat" was very very encouraging. Sounds like the new board and management team are taking a very proactive role in corporate governance, financial planning and business unit strategy. This is LONG overdue. Its been painfully obvious for a couple of years that the company is stretched much too far... they simply have too much on the go with too little capital. The result is they havent done anyone thing particularly well... including creating shareholder value for the few things that they have done extremely well. Its a bit of a shame that the initial news release was so vague. While I think we all appreciate the update on the MVS and the fact that PRDT/MACOPHARMA endogenous study is still looking good, I dont feel as if we learned alot more than that. We certainly didnt learn anything about the "Boards Plan to maximize shareholder value" I sincerely hope that there's more significant stuff forthcoming, I suspect there is.... In general, I really like the fact that the board is getting more involved and specifically there seems to be a true realization that things need to change...and change quickly. I believe we just took a very positive step in that direction despite the fact that the News Release really didnt convey that.
Bullboard Posts